Carbios : H1 results impacted by the opex increase as expected – Pending the first licence signatures
>No sales yet, operating income at -€ 20m - Carbios reported this morning interim earnings broadly in line with our forecasts. With the absence of sales pending the ramp-up of the first plant and the first licence signatures, operating income is, as expected, very negative at -€ 20m (vs -€ 13.3m in H1 2023). Operating costs have increased: i/ R&D costs up 43% to € 8.2m (related mainly to payroll costs, +25 FTEs); ii/ the doubling of commercial and marketing costs at ...Carbios SA, formerly Carbios SASU, is a France-based company engaged in green chemistry that focuses on discovering and developing enzymatic bioprocesses applied to plastic and textile polymers. The Company creates a new generation of fully biodegradable plastics with a controlled lifespan, a process enabling infinite biorecycling of plastic waste (PET) and a new biological pathway for the production of competitive biosourced polymers.
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.